May 16, 2017

Cannabis has made it to the elite world of high level money managers. Last week the elegant Peninsula Hotel in Beverly Hills hosted the 2nd annual Cannabis Private Wealth Summit focused on delivering investment information to family offices. The event operator is out of New York with extensive investment conference experience.

April 25, 2017

The 2nd Annual Cannabis Private Investment Summit WEST takes place May 3, 2017

Peninsula Hotel Hosts Networking Summit for Breaking Into the Billion-Dollar Marijuana Industry

(BEVERLY HILLS, CA) – April 24, 2017– The Annual Cannabis Private Investment Summit WEST will take place on May 3, 2017 at the Peninsula Hotel. For the second year in a row, industry experts and entrepreneurs in branding, real estate, legalization and regulation will gather to explore the opportunities and risks of investing in the marijuana industry and discuss the critical topics currently trending in this sector.

Noa Kahner, CEO of Kahner Global and the founder of the summit says, “We are seeing a unique opportunity to invest in a multi-billion dollar industry that is growing exponentially in the U.S. and abroad. This summit is designed to formalize valuable relationships and educate those seeking to be a part of this historic and rare investment opportunity. Ultra high net worth investors and family offices now have a place to learn about the best investment strategies from thought leaders helping them to capitalize on the legalization of the cannabis industry.”

The recent and ongoing shifts in the regulatory environment have introduced huge business opportunities, especially for those seeking ways to identify and evaluate early stage investments in the cannabis sector. This summit aims to keep investors informed on the rapid changes in this industry while helping them identify business models that will be attractive and sustainable.

Evan Enman, Managing Partner of Casa Verde Capital states, "I was impressed last year with how The Summit was able to bring together sophisticated investors with dynamic entrepreneurs and was excited to be invited back again this year to speak. The conference’s format reinforces the positive messaging coming from within the cannabis sector and helps businesses to network so they can scale in this dynamic international regulatory environment."

The summit will begin with a networking brunch, followed by educational sessions and a cocktail reception. Throughout the day attendees will benefit from peer-to-peer networking, special guest speakers and exclusive access to investment experts. Attendees include family offices, accredited investors, angel investors, wealth managers, venture capital funds, cannabis companies, law firms and accounting firms.

The agenda and additional information can be found at www.cannabrunch.net.

About the Cannabis Private Investment Summit WEST:

The Cannabis Private Investment Summit WEST is a family office series that will explore the opportunities and risks of investing in the cannabis industry. This is the leading cannabis investing educational summit exclusively offered to high net worth investors and family offices.

March 15, 2017

The Fresh Toast called Hawkins to learn more about the investors in the cannabis space, his company, and the common misconceptions people have when it comes to viewing the cannabis industry.

August 18, 2016

DENVER, Aug. 17, 2016 /PRNewswire/ — Leading cannabis company ebbu™ has officially debuted a visionary new brand design crafted to appeal to a broader consumer base and connect with mainstream culture. ebbu’s new brand design coincides with the launch of two new product lines, ebbu™ “Bold” which will feature the release of the company’s patent pending first formulated product, and ebbu™ “Well”.

July 15, 2016

Medical dermatology company Botanix Pharmaceuticals has commenced trading on the Australian Securities Exchange (ASX) following an oversubscribed financing of A$3.5 million ($2.67 million) and its acquisition by Bone Medical Limited in June 2016. Botanix is a medical dermatology company that develops prescription treatments for skin conditions such as acne, psoriasis and atopic dermatitis. Commenting on their listing, executive director Matthew Callahan commented, “Given that acne is the most common skin disease in the world and that our lead product under development is a topically applied 

 

March 30, 2016

Cannabis Private Investment Summit WEST to Take Place May 4

Peninsula Hotel Hosts Networking Summit for Breaking Into the Billion-Dollar Marijuana Industry
 

(BEVERLY HILLS, CA) – March 30, 2016 – The Cannabis Private Investment Summit WEST will be taking place on May 4, 2016, at the Peninsula Hotel in Beverly Hills. Presented by Kahner Global, the family office summit series will explore the opportunities and risks of investing in the cannabis industry. Speakers at the summit will include industry experts, entrepreneurs, and government enforcement officials, as they discuss the critical topics investors should consider.

The cannabis industry is the fastest shifting industry in the United States. The shifting regulatory environment in favor of legal cannabis has brought on huge business opportunities for investors, especially those who are seeking ways to identify and evaluate early stage investment opportunities in the cannabis sector. The summit aims to help investors identify which business models are the most attractive and sustainable, as well as what risks are involved and how family offices should consider investing in the space.

Summit attendees will take part in networking lunch and cocktail reception; educational sessions; peer-to-peer networking; special guest speakers and exclusive access to investment experts. Attendees will include family offices, accredited investors, angel investors, wealth managers, venture capital funds, cannabis companies, law firms and accounting firms.

A preliminary agenda as well as additional information can be found at www.cannabrunch.net.

About the Cannabis Private Investment Summit WEST:

The Cannabis Private Investment Summit WEST is a family office series that will explore the opportunities and risks of investing in the cannabis industry. This is the leading cannabis investing educational summit exclusively offered to high net worth investors and family offices. 

March 29, 2016

TEL AVIV — Already a pioneer in high-tech and cutting-edge agriculture, Israel is starting to attract American companies looking to bring medical marijuana know-how to a booming market back home.

Since 2014, U.S. firms have invested about $50 million (34.9 million pounds) in licensing Israeli medical marijuana patents, cannabis agro-tech startups and firms developing delivery devices such as inhalers, said Saul Kaye, CEO of iCAN, a private cannabis research hub.

"I expect it to grow to $100 million in the coming year," Kaye said at iCAN's CannaTech conference in Tel Aviv this month, one of the largest gatherings of medical marijuana experts.

Scientists say strict rules, some set by the Drug Enforcement Administration, limit cannabis studies in the United States, where the legal marijuana market is valued at $5.7 billion and expected to grow to $23 billion by 2020.

"In the United States it's easier to study heroin than marijuana," said U.S. psychiatrist Suzanne Sisley, who has researched the effects of cannabis as a treatment for American military veterans suffering from Post Traumatic Stress Disorder.

December 18, 2015

It wasn't so many years ago that the words "cannabis gathering" only meant a joint being passed around the room and some sturdy philosophizing about life, the universe, and the bounties of the magic leaf. The picture could not have been more removed from that at the Cannabis Private Investment Summit organized by Kahner Global in New York City a couple of weeks ago. This was a room full of professional suits. On the one side, there were private family offices and high net worth investors potentially wanting to latch on to the exploding legal cannabis industry. On the other side, individuals with established cannabis-related companies pitching their products or services, informing and educating everyone about the opportunities in the space.

December 17, 2015

LOS ANGELES and DENVER, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Dixie Brands, Inc. (Dixie), a leader in emerging cannabinoid extraction and wellness platforms has partnered with California's leading online doctor recommendation and cannabis delivery providers, HelloMD and SpeedWeed, to offer two free Dixie LIFTED products following the completion of online recommendation renewal and medicine purchases through SpeedWeed.
Read more at http://www.econotimes.com/DIXIE-BRANDS-INC-JOINS-SPEEDWEED-AND-HELLOMD-TO-DRIVE-PATIENT-ADOPTION-OF-ONLINE-RECOMMENDATION-AND-DELIVERY-PLATFORM-IN-CALIFORNIA-133220#WMiduEgsmp0KI71d.99

December 13, 2015

In the two years since Colorado began selling marijuana for recreational use, it has become the epicenter of a booming industry, one that will gross over $1 billion in sales this year. That number has been predicted to grow nationally to the point where it's larger than the organic food industry as vast swaths of the United States, as well as Canada, gear up for seemingly inevitable legalization.

With opportunity skyrocketing, Colorado has found itself in the midst of a modern-day "green rush." Entrepreneurs—many from out of town, transplants from corporate America or Silicon Valley—are touching down with ideas to innovate in the cannabis industry and make a fortune on the crop.

December 04, 2019

Following a powerful keynote speech by Drug Policy Alliance Executive Director Ethan Nadelmann, attendees at the Cannabis Private Investment Summit, organized by Noa Kahner of Kahner Global, were treated to a fireside chat between Privateer Holdings CEO Brendan Kennedy and ebbu Founder Dooma Wendschuh. CNBC Anchor Mandy Drury moderated the discussion, which took place in New York City.

November 24, 2015

This year Gateway will back two classes of 10 cannabis startups with $30,000 each plus five months of office space in exchange for 6% of their equity. The cash comes from LA’s Marijuana Investment Corporation (now just known as MJIC), and will fund further rounds for top performers after Gateway’s demo days. Applications, in the form of four-minute videos, open today for the first class starting in 2016.

June 01, 2015

In this featured interview by the Cannabis Financial Network with Dooma Wendschuh, CEO of ebbu, Dooma discusses ebbu and it’s dedication to providing distilled marijuana products that can deliver predicable and reliable results to cannabis users.

November 11, 2015

HelloMD is at the forefront of a new trend in Silicon Valley: the cannabis tech start-up. As marijuana laws are being loosened across the country, entrepreneurs and investors are creating new businesses to cash in on what they see as an emerging bonanza. Like start-ups in other industries, these firms are trying to use technology to bring speed and efficiency to what has long been a face-to-face, pen-and-paper market. In the process, they are also trying to alter mainstream perceptions of the marijuana industry, shedding the ganja and Rasta imagery to cultivate a wider audience.

“What we see is moms, dads, professionals, old people, everyone wanting access to cannabis,” said Mark Hadfield, the founder of HelloMD. “The old type of experience — go to a crummy dispensary, wait in line — was not going to appeal to the market that we were after, which is everyday Americans, a market that, by the way, is much larger than the old market of — I don’t want to call them stoners, but let’s say, ‘recreationally minded young people.’”

May 15, 2015

BreedIT Corp (BRDT) (“BreedIT” or the “Company”), through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers, today is pleased to announce that Colorado based INTIVA Pharma LLC which invests in companies and otherwise participates in the development of pharmaceuticals from cannabinoids, has made an initial $200,000 investment out of a potential $800,000 investment in the Company in the form of straight equity restricted stock at a purchase price of $0.30 per share. INTIVA Pharma is a wholly-owned subsidiary of Global Cannabis Ventures Ltd. (“Global Cannabis”), a company pursuing opportunities in the legal cannabis industry internationally.

November 05, 2015

GreenWave Advisors, LLC an independent financial research and advisory firm serving the burgeoning cannabis industry, will release the second edition of  "The GreenWave Report: State of the Emerging Marijuana Industry – Current Trends and Projections". This report provides an unparalleled state by state review and analysis of market dynamics in the legalized U.S. marijuana markets and provides an outlook for industry growth through 2020.